Your browser doesn't support javascript.
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
Owusu, Daniel; Pomeroy, Mary A; Lewis, Nathaniel M; Wadhwa, Ashutosh; Yousaf, Anna R; Whitaker, Brett; Dietrich, Elizabeth; Hall, Aron J; Chu, Victoria; Thornburg, Natalie; Christensen, Kimberly; Kiphibane, Tair; Willardson, Sarah; Westergaard, Ryan; Dasu, Trivikram; Pray, Ian W; Bhattacharyya, Sanjib; Dunn, Angela; Tate, Jacqueline E; Kirking, Hannah L; Matanock, Almea.
  • Owusu D; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Pomeroy MA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Lewis NM; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Wadhwa A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Yousaf AR; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Whitaker B; Utah Department of Health, Salt Lake City, Utah, USA.
  • Dietrich E; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hall AJ; Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chu V; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Thornburg N; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Christensen K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Kiphibane T; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Willardson S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Westergaard R; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Dasu T; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Pray IW; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bhattacharyya S; Utah Public Health Laboratory, Taylorsville, Utah, USA.
  • Dunn A; Salt Lake County Health Department, Salt Lake City, Utah, USA.
  • Tate JE; Davis County Health Department, Clearfield, Utah, USA.
  • Kirking HL; Wisconsin Department of Health Services, Madison, Wisconsin, USA.
  • Matanock A; City of Milwaukee Health Department, Milwaukee, Wisconsin, USA.
J Infect Dis ; 224(8): 1362-1371, 2021 Oct 28.
Article in English | MEDLINE | ID: covidwho-1112094
ABSTRACT

BACKGROUND:

To better understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding and infectivity, we estimated SARS-CoV-2 RNA shedding duration, described participant characteristics associated with the first negative rRT-PCR test (resolution), and determined if replication-competent viruses was recoverable ≥10 days after symptom onset.

METHODS:

We collected serial nasopharyngeal specimens from 109 individuals with rRT-PCR-confirmed COVID-19 in Utah and Wisconsin. We calculated viral RNA shedding resolution probability using the Kaplan-Meier estimator and evaluated characteristics associated with shedding resolution using Cox proportional hazards regression. We attempted viral culture for 35 rRT-PCR-positive nasopharyngeal specimens collected ≥10 days after symptom onset.

RESULTS:

The likelihood of viral RNA shedding resolution at 10 days after symptom onset was approximately 3%. Time to shedding resolution was shorter among participants aged <18 years (adjusted hazards ratio [aHR], 3.01; 95% confidence interval [CI], 1.6-5.6) and longer among those aged ≥50 years (aHR, 0.50; 95% CI, .3-.9) compared to participants aged 18-49 years. No replication-competent viruses were recovered.

CONCLUSIONS:

Although most patients were positive for SARS-CoV-2 for ≥10 days after symptom onset, our findings suggest that individuals with mild to moderate COVID-19 are unlikely to be infectious ≥10 days after symptom onset.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Virus Shedding / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Virus Shedding / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis